Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anesthesiology ; 92(4): 1002-9, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10754619

RESUMO

BACKGROUND: The aim of this study was to determine the dose or doses of the new rapid-onset, short-acting, neuromuscular blocking drug rapacuronium that would provide satisfactory conditions for tracheal intubation at 60 s in infants and children. METHODS: Sixty-five infants (< 1 yr), 51 younger children (1-6 yr), and 49 older children (7-12 yr) were studied. Anesthesia was induced with thiopental-nitrous oxide-oxygen. Tracheal intubation was attempted 60 s after administration of one of five doses of rapacuronium (0.5, 1.0, 1.5, 2.0, or 2.5 mg/kg) and intubating conditions were assessed using a four-point scale. Following tracheal intubation, anesthesia was maintained with nitrous oxide-oxygen and alfentanil (12.5-50 microg/kg) as necessary. Neuromuscular transmission was monitored in an uncalibrated fashion using an acceleromyograph. RESULTS: Intubating conditions were good or excellent at 60 s in all infants after doses of 1.5 mg/kg or more and in all younger and older children after doses of 2.0 mg/kg or more. The duration of action of rapacuronium was dose- and age-dependent. Mean times to reappearance of the third twitch of the train-of-four (TOF; T3) were less than 10 min in infants at doses of 1.5 mg/kg or less and in younger and older children at doses of 2.0 mg/kg or less. Recovery of T3 after 1.0-2.0 mg/kg rapacuronium was significantly slower in infants compared with younger (P = 0.001) and older (P = 0.02) children. Five adverse experiences were related to rapacuronium administration: Bronchospasm (two instances), tachycardia (one instance), and increased salivation (two instances). None were serious. CONCLUSIONS: Doses of 1.5 and 2.0 mg/kg rapacuronium can produce satisfactory intubating conditions at 60 s in anesthetized infants and children, respectively, and are associated with a short duration of action.


Assuntos
Anestesia Geral , Fármacos Neuromusculares não Despolarizantes/administração & dosagem , Brometo de Vecurônio/análogos & derivados , Fatores Etários , Criança , Pré-Escolar , Relação Dose-Resposta a Droga , Método Duplo-Cego , Eletrocardiografia , Feminino , Humanos , Lactente , Intubação Intratraqueal , Masculino , Miografia , Fármacos Neuromusculares não Despolarizantes/efeitos adversos , Estudos Prospectivos , Transmissão Sináptica/efeitos dos fármacos , Brometo de Vecurônio/administração & dosagem , Brometo de Vecurônio/efeitos adversos
2.
Eur J Anaesthesiol Suppl ; 11: 73-8, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8557011

RESUMO

Two groups of children, aged 1-4 years (n = 28) and 5-10 years (n = 28), respectively, received at random one of four doses of rocuronium (0.12, 0.17, 0.22 or 0.27 mg kg-1). When maximum block was obtained, further rocuronium to a total dose of 0.5 mg kg-1 was given. At a spontaneous T1 recovery of 25% the block was reversed with atropine and neostigmine in half the patients. The remainder were allowed to recover spontaneously. There was no difference in potency in the two age groups. An ED50 of 0.2 mg kg-1 was estimated. The estimates of ED50 were model-dependent of approximately 0.32 mg kg-1. The maximum block was found significantly higher in the younger age group (99.0 +/- 1.5% (mean +/- SD)) as compared to the older group (97.5 +/- 2.3%), and the clinical duration was also longer (16.6 +/- 5.3 min vs. 13.3 +/- 3.8 min), respectively. There was no significant difference between the two age groups in duration90 (26.9 +/- 6.5 min, 22.5 +/- 6.7 min, respectively) and duration0.7 (27.6 +/- 6.0 min, 24.9 +/- 7.9 min, respectively). Recovery time25-75, recovery time25-90, but not recovery time25-0.7 were found significantly longer in the 1-4 year group as compared to the times in older children. Neostigmine administration reduced recovery time by approximately half to two-thirds. MAP was not influenced by rocuronium. Following the injection of rocuronium in the younger age group there was a 15% increase in heart rate compared to a 10% increase in the age group 5-10 years.


Assuntos
Androstanóis , Anestesia , Anestésicos Inalatórios , Halotano , Fármacos Neuromusculares não Despolarizantes , Androstanóis/administração & dosagem , Androstanóis/efeitos adversos , Período de Recuperação da Anestesia , Pressão Sanguínea/efeitos dos fármacos , Criança , Pré-Escolar , Inibidores da Colinesterase/farmacologia , Relação Dose-Resposta a Droga , Feminino , Frequência Cardíaca/efeitos dos fármacos , Humanos , Lactente , Masculino , Músculo Esquelético/efeitos dos fármacos , Neostigmina/farmacologia , Fármacos Neuromusculares não Despolarizantes/administração & dosagem , Fármacos Neuromusculares não Despolarizantes/efeitos adversos , Rocurônio , Fatores de Tempo
3.
Ophthalmologe ; 90(4): 367-71, 1993 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-8374235

RESUMO

Since there will be an increase in the number of geriatric patients who undergo surgery and anesthesia over the next few years, studies comparing the effects of general and local anesthesia on cognitive functioning in elderly persons are mandatory. One hundred eleven ophthalmological patients, all over the age of 64 years, were assessed preoperatively, on the first and on the fourth postoperative day using a battery of standardized cognitive tests. Of the initial sample, 47 patients undergoing local and 54 undergoing general anesthesia completed the assessment. The performance of the patients in six tests did not change perioperatively. In both anesthesia groups, two tests revealed a cognitive deficit postoperatively, which only became evident on the first postoperative day. The two other tests showed a significant difference between the two anesthesia groups on the first postoperative day. The performance of patients with general anesthesia decreased transiently and returned to the initial levels within 3 days. We conclude from our results that postoperative cognitive deficits may occur in geriatric patients. However, general anesthesia poses no more risk to cognitive function than local anesthesia.


Assuntos
Anestesia Geral , Anestesia Local , Anestésicos/efeitos adversos , Oftalmopatias/cirurgia , Complicações Pós-Operatórias/etiologia , Transtornos Relacionados ao Uso de Substâncias/etiologia , Idoso , Idoso de 80 Anos ou mais , Feminino , Avaliação Geriátrica , Humanos , Masculino , Testes Neuropsicológicos , Estudos Prospectivos
4.
Anaesthesiol Reanim ; 18(2): 53-6, 1993.
Artigo em Alemão | MEDLINE | ID: mdl-8397672

RESUMO

Muscle relaxants are essential in anaesthesia for neuroradiological diagnosis. In addition, neurosurgical and neurological patients often face, because of their basic illness, respiratory danger, which can increase postoperatively through the use of muscle relaxants during anaesthesia. Because of their pharmacodynamic properties and side-effects, muscle relaxants must be clearly differentiated from one another and used selectively for the different phases of anaesthesia-intubation, calmness during examination and recovery from neuromuscular block with extubation. During planned extubation in particular, no residual relaxation or danger of recurarization must exist during the recovery stage from neuromuscular block. For investigations with planned extubation, only the muscle relaxants atracurium and vecuronium with their medium-long effect should be applied. A high degree of safety is provided by neuromuscular block and especially in the recovery phase. Using relaxometers it is possible to determine individual relaxant requirements, avoid under- and overdoses, carry out an antagonism at the correct time and prevent residual relaxation situations so that respiratory insufficiency can be reliably excluded.


Assuntos
Anestesia/métodos , Bloqueadores Neuromusculares/farmacologia , Junção Neuromuscular/efeitos dos fármacos , Fármacos Neuromusculares não Despolarizantes/farmacologia , Humanos
5.
Anaesthesia ; 46(10): 856-8, 1991 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1952002

RESUMO

Intravenous nifedipine was administered to treat arterial hypertension in a 54-year-old woman presenting for removal of a meningioma. A marked decrease in arterial oxygen tension occurred during the nifedipine infusion. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine is discussed.


Assuntos
Complicações Intraoperatórias/etiologia , Nifedipino/efeitos adversos , Oxigênio/sangue , Artérias , Depressão Química , Feminino , Humanos , Hipóxia/induzido quimicamente , Infusões Intravenosas , Pessoa de Meia-Idade , Nifedipino/administração & dosagem , Pressão Parcial
6.
Anasth Intensivther Notfallmed ; 17(4): 237-9, 1982 Aug.
Artigo em Alemão | MEDLINE | ID: mdl-7137545

RESUMO

Catheterisation of the axillar artery for the control of blood pressure and blood gases is described. The advantages over puncturing of small arteries consist in the lower risk of thromboembolic complications and the greater accuracy in blood pressure measurement. Compared with the a. femoralis, the a. axillaris offers the advantages of better intraoperative accessibility, lower risk of contamination and better mobility of the patient. Out of 120 patients who received an a. axillaris catheter preoperatively or in the intensive-care ward for control purposes, complications occurred in 12 cases (haematomas after decannulation, disturbed sensitivity, thrombus at the vascular wall, kinking and obstruction of the catheter), which, however, did not give rise to any clinical sequels.


Assuntos
Artéria Axilar , Gasometria/métodos , Determinação da Pressão Arterial/métodos , Cateterismo/métodos , Adulto , Idoso , Cateteres de Demora , Feminino , Hematoma/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Trombose/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...